Patrick et al. [11] found that patients with atopic dermatitis (AD) had elevated levels of IL-36α and IL-36γ in peripheral serum, and IL-36α promoted IgE production by B cells in vitro through activation of IL-36R. The gene discussed is IL36A; the disease is atopic eczema.